BIOMARIN PHARMACEUTICAL INC Deferred Income Tax Expense (Benefit)
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Deferred Income Tax Expense (Benefit) of $2.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$6.96M, a 120.87% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $9.22M, a 67.57% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $613.00K, a 98.55% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC deferred income tax expense (benefit) for the quarter ending 2025-09-30 was -$13.65M, a 212.11% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC deferred income tax expense (benefit) for fiscal 2025 was $48.74M, a 13.12% decline from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC deferred income tax expense (benefit) for fiscal 2024 was $56.10M.
- BIOMARIN PHARMACEUTICAL INC deferred income tax expense (benefit) for fiscal 2023 was -$44.98M.
- BIOMARIN PHARMACEUTICAL INC deferred income tax expense (benefit) for fiscal 2022 was -$52.09M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 3 month as first filed | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.26M 10-Q · filed 2026-08-06 | $2.87M derived: sum of 3 quarters · filed 2026-08-06 | -$10.77M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $9.22M 10-Q · filed 2026-05-05 | $9.83M derived: sum of 2 quarters · filed 2026-05-05 | -$3.81M derived: sum of 3 quarters · filed 2026-05-05 | $29.53M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$13.03M derived: sum of 2 quarters · filed 2026-02-26 | $20.31M derived: sum of 3 quarters · filed 2026-08-06 | $48.74M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$13.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $19.70M derived: sum of 2 quarters · filed 2026-08-06 | $48.13M 10-Q · filed 2025-10-28 | $90.51M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $33.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $61.77M 10-Q · filed 2026-08-06 | $104.16M derived: sum of 3 quarters · filed 2026-08-06 | $116.33M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $28.43M 10-Q · filed 2026-05-05 | $70.82M derived: sum of 2 quarters · filed 2026-05-05 | $82.99M derived: sum of 3 quarters · filed 2026-05-05 | $84.24M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $42.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $54.56M derived: sum of 2 quarters · filed 2026-02-26 | $55.81M derived: sum of 3 quarters · filed 2026-02-26 | $56.10M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $12.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $13.42M derived: sum of 2 quarters · filed 2025-10-28 | $13.71M 10-Q · filed 2025-10-28 | -$11.13M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.54M 10-Q · filed 2025-08-05 | -$23.31M derived: sum of 3 quarters · filed 2026-02-26 | -$38.34M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $285.00K 10-Q · filed 2025-05-02 | -$24.56M derived: sum of 2 quarters · filed 2026-02-26 | -$39.59M derived: sum of 3 quarters · filed 2026-02-26 | -$38.34M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$24.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$39.87M derived: sum of 2 quarters · filed 2026-02-26 | -$38.62M derived: sum of 3 quarters · filed 2026-02-26 | -$44.98M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | -$15.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$13.78M derived: sum of 2 quarters · filed 2024-10-31 | -$20.14M 10-Q · filed 2024-10-31 | -$71.48M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2023-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$5.11M 10-Q · filed 2024-08-05 | -$56.45M derived: sum of 3 quarters · filed 2025-02-24 | -$60.65M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2023-03-31 | -$6.36M 10-Q · filed 2024-04-26 | -$57.70M derived: sum of 2 quarters · filed 2025-02-24 | -$61.90M derived: sum of 3 quarters · filed 2025-02-24 | -$63.25M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2022-12-31 | -$51.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | -$55.54M derived: sum of 2 quarters · filed 2025-02-24 | -$56.89M derived: sum of 3 quarters · filed 2025-02-24 | -$52.09M 10-K · filed 2025-02-24 | ||||
| 2022-09-30 | -$4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$5.54M derived: sum of 2 quarters · filed 2023-11-02 | -$743.00K 10-Q · filed 2023-11-02 | -$4.33M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $3.46M 10-Q · filed 2023-08-02 | -$133.00K derived: sum of 3 quarters · filed 2024-02-26 | -$13.36M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $4.80M 10-Q · filed 2023-04-28 | $1.21M derived: sum of 2 quarters · filed 2024-02-26 | -$12.01M derived: sum of 3 quarters · filed 2024-02-26 | -$14.14M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | -$3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$16.81M derived: sum of 2 quarters · filed 2024-02-26 | -$18.94M derived: sum of 3 quarters · filed 2024-02-26 | -$15.61M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | -$13.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$15.36M derived: sum of 2 quarters · filed 2022-10-28 | -$12.02M 10-Q · filed 2022-10-28 | -$47.81M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | -$2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.20M 10-Q · filed 2022-08-04 | -$34.59M derived: sum of 3 quarters · filed 2023-02-27 | -$882.92M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $3.33M 10-Q · filed 2022-04-29 | -$32.46M derived: sum of 2 quarters · filed 2023-02-27 | -$880.79M derived: sum of 3 quarters · filed 2023-02-27 | -$897.26M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | -$35.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$884.13M derived: sum of 2 quarters · filed 2023-02-27 | -$900.60M derived: sum of 3 quarters · filed 2023-02-27 | -$889.99M 10-K · filed 2023-02-27 | -$888.91M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | -$848.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$864.80M derived: sum of 2 quarters · filed 2021-10-29 | -$854.20M 10-Q · filed 2021-10-29 | -$877.18M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | -$16.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$5.86M 10-Q · filed 2021-07-30 | -$28.84M derived: sum of 3 quarters · filed 2022-02-25 | -$74.04M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $10.60M 10-Q · filed 2021-04-30 | -$12.38M derived: sum of 2 quarters · filed 2022-02-25 | -$57.58M derived: sum of 3 quarters · filed 2022-02-25 | -$84.68M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | -$22.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$68.18M derived: sum of 2 quarters · filed 2022-02-25 | -$95.28M derived: sum of 3 quarters · filed 2022-02-25 | -$82.76M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | -$45.20M 10-Q/A · filed 2019-11-04 | -$72.30M derived: sum of 2 quarters · filed 2019-11-04 | -$59.78M 10-Q · filed 2020-11-06 | -$108.65M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | -$27.10M 10-Q/A · filed 2019-11-04 | -$10.08M 10-Q · filed 2020-08-05 | -$63.45M derived: sum of 3 quarters · filed 2021-02-26 | -$66.50M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | -$704.00K 10-Q · filed 2020-05-01 | -$36.35M derived: sum of 2 quarters · filed 2021-02-26 | -$39.40M derived: sum of 3 quarters · filed 2021-02-26 | -$55.09M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | -$35.64M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | -$38.70M derived: sum of 2 quarters · filed 2021-02-26 | -$54.39M derived: sum of 3 quarters · filed 2021-02-26 | -$68.38M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | -$3.05M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04 | -$18.75M derived: sum of 2 quarters · filed 2019-11-04 | -$32.73M 10-Q/A · filed 2019-11-04 | $47.88M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | -$15.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$29.68M 10-Q · filed 2019-08-02 | $50.93M derived: sum of 3 quarters · filed 2020-02-27 | $37.55M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$13.99M 10-Q · filed 2019-04-29 | $66.63M derived: sum of 2 quarters · filed 2020-02-27 | $53.25M derived: sum of 3 quarters · filed 2020-02-27 | $40.92M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $80.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $67.23M derived: sum of 2 quarters · filed 2020-02-27 | $54.91M derived: sum of 3 quarters · filed 2020-02-27 | $44.46M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$13.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | -$25.71M derived: sum of 2 quarters · filed 2018-10-26 | -$36.15M 10-Q · filed 2018-10-26 | -$45.50M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | -$12.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$22.77M 10-Q · filed 2018-08-03 | -$32.12M derived: sum of 3 quarters · filed 2019-02-28 | -$59.69M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | -$10.44M 10-Q · filed 2018-04-27 | -$19.80M derived: sum of 2 quarters · filed 2019-02-28 | -$47.36M derived: sum of 3 quarters · filed 2019-02-28 | -$217.13M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | -$9.35M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$36.92M derived: sum of 2 quarters · filed 2019-02-28 | -$206.69M derived: sum of 3 quarters · filed 2019-02-28 | -$228.05M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | -$27.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$197.33M derived: sum of 2 quarters · filed 2017-10-31 | -$218.70M 10-Q · filed 2017-10-31 | -$206.69M 10-Q · filed 2016-11-03 | -$310.16M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2016-06-30 | -$169.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$191.13M 10-Q · filed 2017-08-02 | -$184.49M 10-Q · filed 2016-08-08 | -$282.59M derived: sum of 3 quarters · filed 2018-02-26 | -$253.01M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2016-03-31 | -$21.37M 10-Q · filed 2017-05-04 | -$19.28M 10-Q · filed 2016-05-02 | -$112.82M derived: sum of 2 quarters · filed 2018-02-26 | -$83.24M derived: sum of 3 quarters · filed 2018-02-26 | -$90.39M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2015-12-31 | -$91.46M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$61.88M derived: sum of 2 quarters · filed 2018-02-26 | -$69.03M derived: sum of 3 quarters · filed 2018-02-26 | -$76.83M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $29.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $22.43M derived: sum of 2 quarters · filed 2016-11-03 | $14.63M 10-Q · filed 2016-11-03 | $1.39M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | -$7.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$14.95M 10-Q · filed 2016-08-08 | -$28.20M derived: sum of 3 quarters · filed 2017-02-27 | -$35.85M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | -$7.80M 10-Q · filed 2016-05-02 | -$21.04M derived: sum of 2 quarters · filed 2017-02-27 | -$28.70M derived: sum of 3 quarters · filed 2017-02-27 | -$33.24M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | -$13.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$20.89M derived: sum of 2 quarters · filed 2017-02-27 | -$25.44M derived: sum of 3 quarters · filed 2017-02-27 | -$25.62M 10-K · filed 2017-02-27 | -$25.48M 10-K · filed 2015-03-02 | |||
| 2014-09-30 | -$7.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$12.19M derived: sum of 2 quarters · filed 2015-11-02 | -$12.37M 10-Q · filed 2015-11-02 | -$2.07M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$4.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$4.72M 10-Q · filed 2015-08-05 | $5.58M derived: sum of 3 quarters · filed 2016-02-29 | -$3.90M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$179.00K 10-Q · filed 2015-05-05 | $10.13M derived: sum of 2 quarters · filed 2016-02-29 | $638.00K derived: sum of 3 quarters · filed 2016-02-29 | -$9.04M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $10.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $817.00K derived: sum of 2 quarters · filed 2016-02-29 | -$8.86M derived: sum of 3 quarters · filed 2016-02-29 | -$8.90M 10-K · filed 2016-02-29 | -$9.16M 10-K · filed 2014-02-26 | |||
| 2013-09-30 | -$9.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | -$19.17M derived: sum of 2 quarters · filed 2014-10-28 | -$19.21M 10-Q · filed 2014-10-28 | -$18.52M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | -$9.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$9.72M 10-Q · filed 2014-07-31 | -$9.03M derived: sum of 3 quarters · filed 2015-03-02 | -$19.79M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | -$43.00K 10-Q · filed 2014-05-02 | $646.00K derived: sum of 2 quarters · filed 2015-03-02 | -$10.11M derived: sum of 3 quarters · filed 2015-03-02 | -$10.68M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $689.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$10.06M derived: sum of 2 quarters · filed 2015-03-02 | -$10.63M derived: sum of 3 quarters · filed 2015-03-02 | -$9.92M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | -$10.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$11.32M derived: sum of 2 quarters · filed 2013-10-28 | -$10.61M 10-Q · filed 2013-10-28 | -$13.09M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-06-30 | -$569.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $143.00K 10-Q · filed 2013-07-29 | -$2.34M derived: sum of 3 quarters · filed 2014-02-26 | -$2.49M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-03-31 | $712.00K 10-Q · filed 2013-04-29 | -$1.77M derived: sum of 2 quarters · filed 2014-02-26 | -$1.92M derived: sum of 3 quarters · filed 2014-02-26 | $1.17M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2011-12-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | -$2.63M derived: sum of 2 quarters · filed 2014-02-26 | $453.00K derived: sum of 3 quarters · filed 2014-02-26 | $4.36M 10-K · filed 2014-02-26 | ||||
| 2011-09-30 | -$149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $2.93M derived: sum of 2 quarters · filed 2012-10-29 | $6.84M 10-Q · filed 2012-10-29 | -$668.00K derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $6.99M 10-Q · filed 2012-08-02 | -$519.00K derived: sum of 3 quarters · filed 2013-02-26 | -$223.58M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $3.91M 10-Q · filed 2012-04-30 | -$3.60M derived: sum of 2 quarters · filed 2013-02-26 | -$226.67M derived: sum of 3 quarters · filed 2013-02-26 | -$226.67M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | -$7.51M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$230.58M derived: sum of 2 quarters · filed 2013-02-26 | -$230.58M derived: sum of 3 quarters · filed 2013-02-26 | -$230.58M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | -$223.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$223.06M derived: sum of 2 quarters · filed 2011-10-31 | -$223.06M 10-Q · filed 2011-10-31 | -$223.06M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $0.00 10-Q · filed 2011-08-01 | $0.00 derived: sum of 3 quarters · filed 2012-02-22 | |||||
| 2010-03-31 | $0.00 10-Q · filed 2011-04-29 | $0.00 derived: sum of 2 quarters · filed 2012-02-22 | ||||||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $0.00 10-K · filed 2012-02-22 | ||||||
| 2009-09-30 | $0.00 10-Q · filed 2010-10-29 | |||||||
| 2008-12-31 | $0.00 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |